Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Patient Injection Satisfaction With Two Formulations of Glatiramer Acetate
NCT01167426Phase 3Completed
- Sponsor
- Teva Pharmaceutical Industries Ltd.
- Start
- Jul 2010
- Primary completion
- Nov 2010
- Modality
- Peptides, Recombinant Proteins and Enzymes
01
Overview
A Phase 3 trial of glatiramer acetate in multiple sclerosis (MS), sponsored by Teva Pharmaceutical Industries Ltd.. Started Jul 2010; status: completed.
02
Drugs
glatiramer acetate
03
Conditions
multiple sclerosis (MS)
Beyond the preview
Go deeper on NCT01167426.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01167426.